Skip to main content
The CRISPR Journal logoLink to The CRISPR Journal
. 2018 Oct 23;1(5):304–305. doi: 10.1089/crispr.2018.0043

A Unified Resource for Tracking Anti-CRISPR Names

Joseph Bondy-Denomy 1,,*,, Alan R Davidson 2,,*,, Jennifer A Doudna 3,,4,,5,,6,,7,,8,,9, Peter C Fineran 10, Karen L Maxwell 11, Sylvain Moineau 12, Xu Peng 13, Eric J Sontheimer 14, Blake Wiedenheft 15
PMCID: PMC10625466  PMID: 31021273

Dear editors

In the battle between CRISPR-Cas* prokaryotic immune systems and the elements that they target, a diverse array of “anti-CRISPR” proteins have evolved. These proteins appear to have arisen independently multiple times in evolution and function through diverse mechanisms to inhibit CRISPR-Cas immunity. For comprehensive reviews on anti-CRISPRs, we direct readers to recent publications.1,2

Due to the increasing interest in anti-CRISPRs, many new families of these proteins have been discovered in the past year or so. There are now 36 distinct families of anti-CRISPRs described in the literature that block seven subtypes of CRISPR-Cas systems.3–12 In 2015, a naming system for anti-CRISPR genes and proteins was introduced.6,13 To date, this system has been followed in all subsequent publications describing newly discovered anti-CRISPRs. However, as the rate of anti-CRISPR discovery will likely accelerate in the coming years, we feel that it would be advantageous to establish a database for the registration and tracking of anti-CRISPR names.

The primary goal of this database will be to prevent redundant names being used in publications, thus avoiding confusion in the literature. Anti-CRISPR proteins are named according to the subtype they inhibit and the order in which they were discovered—for example, AcrIF1 was the first anti-CRISPR protein identified to inhibit the type I-F system. The database (a Google document) can be found here: https://tinyurl.com/anti-CRISPR

We propose that this document be updated when researchers have had a manuscript accepted for publication in which new anti-CRISPRs are described. We suggest that the authors upload relevant data to the spreadsheet, including the name, CRISPR-Cas subtype inhibited, reference, and amino-acid sequence of the anti-CRISPR (Table 1). This spreadsheet may also be utilized by those preparing a manuscript for submission to ensure that they use anti-CRISPR names that are still available.

Table 1.

A “Screenshot” from the Database, Depicting the Organization of Anti-CRISPR Entries

Acr name Type Inhibited Species of origin Type of genomic element Reference (First author, year, journal) Sequence
AcrIF1 I-F Pseudomonas aeruginosa Phage Bondy-Denomy, 2013, Nature MKFIKYLSTAHLNYMNIAVYENGS
AcrIF2 I-F Pseudomonas aeruginosa Phage Bondy-Denomy, 2013, Nature MIAQQHKDTVAACEAAEAIAIAKD
AcrIF3 I-F Pseudomonas aeruginosa Phage Bondy-Denomy, 2013, Nature MSSTISDRIISRSVIEAARFIQSWE

To avoid the listing of many orthologues, we propose that the database only contain one entry per Acr, which will be considered the “type” Acr for that sequence family. In a case where a paper has investigated proteins that are homologous to an Acr protein, authors should utilize a subscript (e.g., AcrIF6Pae) to denote the species in which the anti-CRISPR is found. When multiple proteins from one species are investigated, we suggest a format of AcrIF6Pae-1, AcrIF6Pae-2, and so on. The established conventions for naming anti-CRISPR proteins and genes will be described as part of the database. We view this as an open repository for the field and as a complementary resource to a previously described anti-CRISPR database.14

Two of us (J.B.-D. and A.R.D.) were inspired to establish this database by the success of the CRISPR-Cas classification scheme in bringing order to the naming of Cas proteins.15,16 This work has been tremendously valuable for advancing the CRISPR-Cas field. We hope that our contribution to the anti-CRISPR field as presented here will provide a similar long-term benefit.

*

Clustered Regularly Interspaced Short Palindromic Repeats.

References

  • 1.Borges AL, Davidson AR, Bondy-Denomy J. The discovery, mechanisms, and evolutionary impact of anti-CRISPRs. Annu Rev Virol 2017;4:37–59. DOI: 10.1146/annurev-virology-10141-041616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pawluk A, Davidson AR, Maxwell KL. Anti-CRISPR: discovery, mechanism and function. Nat Rev Micro 2018;16:12–17. DOI: 10.1038/nrmicro.2017.120. [DOI] [PubMed] [Google Scholar]
  • 3.Bondy-Denomy J, Pawluk A, Maxwell KL, et al. . Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013;493:429–432. DOI: 10.1038/nature11723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pawluk A, Bondy-Denomy J, Cheung VHW, et al. . A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa. mBio 2014;5:e00896-14. DOI: 10.1128/mBio.00896-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pawluk A, Staals RH, Taylor C, et al. . Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat Microbiol 2016;1:1608–5.. DOI: 10.1038/nmicrobiol.2016.85. [DOI] [PubMed] [Google Scholar]
  • 6.Pawluk A, Amrani N, Zhang Y, et al. . Naturally occurring off-switches for CRISPR-Cas9. Cell 2016;167:1829–1838.e9. DOI: 10.1016/j.cell.2016.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rauch BJ, Silvis MR, Hultquist JF, et al. . Inhibition of CRISPR-Cas9 with bacteriophage proteins. Cell 2017;168:150–158.e10. DOI: 10.1016/j.cell.2016.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hynes AP, Rousseau GM, Lemay ML, et al. . An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nat Microbiol 2017;2:1315–1380. DOI: 10.1038/s41564-017-0004-7. [DOI] [PubMed] [Google Scholar]
  • 9.He F, Bhoobalan-Chitty Y, Van LB, et al. . Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity. Nat Microbiol 2018;3:461–469. DOI: 10.1038/s41564-018-0120-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hynes AP, Rousseau GM, Agudelo D, et al. . Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins. Nat Commun 2018;9:291–9.. DOI: 10.1038/s41467-018-05092-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Marino ND, Zhang JY, Borges AL, et al. . Discovery of widespread type I and type V CRISPR-Cas inhibitors. Science 2018. Sep 6 [Epub ahead of print]; DOI: 10.1126/science.aau5174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Watters KE, Fellmann C, Bai HB, et al. . Systematic discovery of natural CRISPR-Cas12a inhibitors. Science 2018. Sep 6 [Epub ahead of print]; DOI: 10.1126/science.aau5138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bondy-Denomy J, Garcia B, Strum S, et al. . Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature 2015;526:136–139. DOI: 10.1038/nature15254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dong C, Hao GF, Hua HL, et al. . Anti-CRISPRdb: a comprehensive online resource for anti-CRISPR proteins. Nucleic Acids Res 2018;46:D393–D398. DOI: 10.1093/nar/gkx835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Makarova KS, Haft DH, Barrangou R, et al. . Evolution and classification of the CRISPR-Cas systems. Nat Rev Micro 2011;9:467–477. DOI: 10.1038/nrmicro2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Makarova KS, Wolf YI, Alkhnbashi OS, et al. . An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Micro 2015;13:722–736. DOI: 10.1038/nrmicro3569. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The CRISPR Journal are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES